Aligos Therapeutics (ALGS) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-13.08
-8.47
-3.86
0.75

Details

Expected EPS
-2.9775
Actual EPS
-2.11
Surprise EPS
0.87
Surprise Percent
+29.14%

Description

⁨Aligos Therapeutics⁩ (⁦ALGS⁩) has reported earnings of ⁦-2.11⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts